14 Why the Difference MattersThe activation of two distinct hormonal pathways (GIP and GLP-1) by tirzepatide, compared to the single pathway (GLP-1) activated by semaglutide, is believed to be the underlying reason for the generally greater effects on weight loss and blood sugar control observed with tirzepatide in clinical studies.32 This dual mechanism provides a plausible scientific basis for why one drug might demonstrate more pronounced results than the other
Novo Nordisk, the Danish drugmaker that manufactures three of the most popular formulations Ozempic, Rybelsus, and Wegovy is conducting a pregnancy registry for Wevogy (the only one of the three approved for use specifically in weight loss), in which it will compare pregnancy outcomes for people exposed to Wegovy during pregnancy, and overweight and obese people who were not exposed during pregnancy
This rationale spurred extensive investigation of diverse probiotic strains during the SARS-CoV-2 pandemic
The combination is biochemically logical, but there is not yet a strong human trial proving that NMN + TMG yields better longevity outcomes than NMN alone
The 27% increased pneumonia risk per additional broken rib in those over 65 makes any recovery acceleration particularly valuable for older Canadians